Policy

Policy articles provide in-depth analysis of social and public policy, examining their wide-ranging impacts on economics, social life, public health, individual liberty, evidence-based decision-making, and institutional accountability.

We cover critical areas such as healthcare and vaccination policies, pandemic responses and WHO, economic subsidies, national security strategies, withdrawals from international bodies, and pathways to reform that restore freedom, truth, and human dignity over centralized control.

All articles from Brownstone Institute are translated into multiple languages to support global access, foster international dialogue on governance and reform, and empower readers worldwide to challenge flawed interventions.

NIH Director Details Crackdown on Fees Monopoly Publishers Charge

NIH Director Details Crackdown on Fees Monopoly Publishers Charge

SHARE | PRINT | EMAIL

In an exclusive interview with The DisInformation Chronicle, National Institutes of Health Director Jay Bhattacharya explains his latest policy to control monopoly science publishers now raking in hundreds of millions of dollars from taxpayers.

NIH Director Details Crackdown on Fees Monopoly Publishers Charge Read Journal Article

REPPARE University of Leeds - Brownstone Institute

Rethinking US Global Health Funding: Welcome, and Long Overdue

SHARE | PRINT | EMAIL

We agree that the international community should continue to support less-resourced members. However, we disagree that this should consist of perpetual and increasing payments to centralized agencies such as GFATM, GAVI, and the Pandemic Fund, or donor bureaucracies like USAID.

Rethinking US Global Health Funding: Welcome, and Long Overdue Read Journal Article

Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns

Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns

SHARE | PRINT | EMAIL

Levi is no stranger to weighing risk. A professor at MIT with deep experience in data analytics and risk-based decision-making, he had combed through five clinical trials of RSV monoclonals, including clesrovimab and its predecessor, nirsevimab.

Retsef Levi Explains His Vote against Routine RSV Monoclonal Use in Newborns Read Journal Article

Did Covid Vaccines Really Save Millions?

Did Covid Vaccines Really Save Millions?

SHARE | PRINT | EMAIL

Our research team undertook a structured, step-by-step evaluation of the empirical foundations of the “millions saved” narrative. We critically examined the hypothetical statistical models that produced this extraordinary figure, as well as multiple randomized controlled trials and large-scale observational studies.

Did Covid Vaccines Really Save Millions? Read Journal Article

Innovative Health Financing Mechanisms for Advancing Pandemic Preparedness: ‘Huge Untapped Potential’ or False Advertising?

Innovative Health Financing Mechanisms for Advancing Pandemic Preparedness: ‘Huge Untapped Potential’ or False Advertising?

SHARE | PRINT | EMAIL

Innovative financing looks to be yet more false advertising for global health financing reform, where its ‘huge untapped potential’ mainly lies with how to further promote vested interests at the expense of comprehensive global public health.

Innovative Health Financing Mechanisms for Advancing Pandemic Preparedness: ‘Huge Untapped Potential’ or False Advertising? Read Journal Article

Join the Brownstone Community
Get our FREE Journal Newsletter